Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck

American Journal of Pathology

Volumn 159, Issue 5, 2001, Pages 1917-1924

  Holley, Sarah L ^a   Parkes, Gary ^b   Matthias, Christoph ^c   Bockmühl, Ulrike ^c   Jahnke, Volker ^c   Leder, Korinna ^c   Strange, Richard C ^a   Fryer, Anthony A ^a   Hoban, Paul R ^a  

^a KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b STAFFORDSHIRE GENERAL HOSPITAL   (United Kingdom)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MESSENGER RNA;

ARTICLE; CANCER REGRESSION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL; RNA SPLICING; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION;

EID: 0035157857     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63038-6     Document Type: Article

References (42)

1. Potentially malignant lesions and conditions of the mouth and oropharynx: Natural history - Cellular and molecular markers of risk
2. Upper aerodigestive tract cancers
3. Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: A prospective analysis
4. Prognostic factors for head and neck tumour recurrence
5. Cell kinetics of head and neck cancers
6. Vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen
7. Prognostic significance of cell kinetics in laryngeal squamous cell carcinomas: Clinical pathological associations
8. Cancer cell cycles
9. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts
10. Cyclin D1 induction in breast cancer cells shorten G1 and is sufficient for cells arrested in G1 to complete the cell cycle
11. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in head and neck squamous cell carcinoma
12. PRAD-1/cyclin D1 gene amplification correlates with messenger mRNA overexpression and tumour progression in human laryngeal carcinomas
13. Overexpression of cyclin D1 correlates with recurrence in a group of forty seven operable squamous cell carcinomas of the head and neck
14. Cyclin D1 overexpression in primary hypolaryngeal carcinomas
15. Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma
16. Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma
17. Antisense inhibition of cyclin D1 in human head and neck squamous cell carcinoma
18. Alternate splicing produces a novel cyclin D1 transcript
19. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck
20. Cyclin D1, glutathione S-transferase and cytochrome P450 genotypes and outcome in patients with upper aerodigestive tract cancers: Assessment of the importance of individual genes using multivariate analysis
21. Hae III polymorphism with 3′ untranslated region of PRAD 1
22. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small cell lung cancer
23. Expression and subcellular localisation of cyclin D1 protein in ovarian epithelial tumour cells
24. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancers
25. Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis
26. Expression of cyclin D1 and EMS in bladder tumours: Relationship with chromosome 11q13 amplification
27. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining
28. Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy
29. Determination of the prognostic value of cyclin D1 overexpression in breast cancer
30. Cyclin D1 amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis
31. Perturbation of cell cycle regulators in human cancer
32. A novel cyclin encoded by a bcl-1 linked candidate oncogene
33. Cyclins and their associated cyclin-dependent kinases in the human cell cycle
34. Alternatively spliced forms of cyclin D1 modulate entry into cell cycle in an inverse manner
35. Cyclin D1/PRAD1/ BCL-1 alternative transcript [B] protein product in B-lymphoid malignancies with t (11;14)(q13;32) translocation
36. A potential mechanism for fumonisin B (1)-mediated hepatocarcinogenesis: Cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3β activity
37. Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma
38. Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer
39. CDK-independent activation of estrogen receptor by cyclin D1
40. D-Type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability